---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-297169"
form_type: "8-K"
ticker: "VERU"
cik: "0000863894"
company_name: "VERU INC."
filed_at: "2023-12-18T23:59:59+00:00"
generated_at: "2026-06-07T11:34:20.364986+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Veru prices public offering of 45.8M shares at $0.72, net proceeds ~$35.2M for enobosarm trial

## Summary
- Entered underwriting agreement for 45,833,333 shares at $0.72/share; gross proceeds ~$33M.
- Underwriters' option for 6,874,999 additional shares exercised in full on Dec 15.
- Net proceeds expected ~$35.2M after discounts and expenses.
- Proceeds primarily fund Phase 2b trial of enobosarm for muscle preservation in obese elderly on GLP-1 agonists.
- Offering expected to close Dec 18, 2023; Raymond James and Oppenheimer lead.

## SEC filing metadata
- accession: 0001193125-23-297169
- form_type: 8-K
- ticker: VERU
- cik: 0000863894
- company_name: VERU INC.
- filed_at: 2023-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/863894/000119312523297169/0001193125-23-297169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/863894/000119312523297169/d584595d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-297169
- JSON: https://secwatch.observer/filing/0001193125-23-297169.json
- Plain text: https://secwatch.observer/filing/0001193125-23-297169.txt

## Key facts
- Material Agreements
  VERU INC. entered into Underwriting Agreement with Raymond James & Associates, Inc. and Oppenheimer & Co. Inc. valued at Offering of 45,833,333 shares of common stock at $0.72 per share, net proceeds approximately $35.2 m (effective 2023-12-14).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Raymond James & Associates, Inc. and Oppenheimer & Co. Inc.
  - Value: Offering of 45,833,333 shares of common stock at $0.72 per share, net proceeds approximately $35.2 m
  - Effective: 2023-12-14
  source text: On December 14, 2023, Veru Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the underwriters named therein (the “Underwriters”), relating to the offering, issuance and sale (the “Offering”) of 45,833,333 shares of the Company’s common stock, par value $0.01 per share, at a public offering price of $0.72 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/863894/000119312523297169/0001193125-23-297169-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.